Neuroscience
Glucagon Like Peptide 2
100%
Gastric Inhibitory Polypeptide
100%
Crossover Study
100%
Placebo
100%
Bone Resorption
28%
Amino Terminal Sequence
28%
Procollagen
28%
Receptor
14%
In Vitro
14%
Collagen Type 1
7%
Telopeptide
7%
Scanning Electron Microscopy
7%
Gastric Inhibitory Polypeptide Receptor
7%
C-Terminus
7%
Receptor Antagonist
7%
Medicine and Dentistry
Bone Turnover
100%
Gastric Inhibitory Polypeptide
100%
Placebo
100%
Glucagon Like Peptide 2
100%
Osteolysis
26%
Procollagen
26%
Amino Terminal Sequence
26%
Receptor
20%
In Vitro
13%
Scanning Electron Microscopy
6%
C-Terminal Telopeptide
6%
Ossification
6%
Collagen Type 1
6%
Clinical Trial
6%
Receptor Antagonist
6%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide-2
100%
Bone Turnover
100%
Gastric Inhibitory Polypeptide
100%
Osteolysis
28%
N-Terminus
28%
Receptor Antagonist
7%
Gastric Inhibitory Polypeptide Receptor
7%
C-Terminal Telopeptide
7%
Scanning Electron Microscopy
7%
Type I Collagen
7%
In Vitro Study
7%
Clinical Trial
7%
Ossification
7%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Gastric Inhibitory Polypeptide
100%
Glucagon Like Peptide 2
100%
Procollagen
28%
Receptor
14%
Scanning Electron Microscopy
7%
Receptor Antagonist
7%
Collagen Type 1
7%
Telopeptide
7%
Clinical Trial
7%
Gastric Inhibitory Polypeptide Receptor
7%
Keyphrases
Glucose-dependent Insulinotropic Polypeptide Receptor
7%